BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25248875)

  • 1. Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics.
    Fukuno K; Hara T; Tsurumi H; Shibata Y; Mabuchi R; Nakamura N; Kitagawa J; Shimizu M; Ito H; Saito K; Moriwaki H
    Leuk Lymphoma; 2015 May; 56(5):1398-405. PubMed ID: 25248875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression.
    Mangaonkar A; Mondal AK; Fulzule S; Pundkar C; Park EJ; Jillella A; Kota V; Xu H; Savage NM; Shi H; Munn D; Kolhe R
    Sci Rep; 2017 Oct; 7(1):12892. PubMed ID: 29038460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia.
    Mabuchi R; Hara T; Matsumoto T; Shibata Y; Nakamura N; Nakamura H; Kitagawa J; Kanemura N; Goto N; Shimizu M; Ito H; Yamamoto Y; Saito K; Moriwaki H; Tsurumi H
    Leuk Lymphoma; 2016; 57(1):92-8. PubMed ID: 25907424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review.
    Wells G; Kennedy PT; Dahal LN
    Front Immunol; 2021; 12():651687. PubMed ID: 33777052
    [No Abstract]   [Full Text] [Related]  

  • 5. High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome.
    Chamuleau ME; van de Loosdrecht AA; Hess CJ; Janssen JJ; Zevenbergen A; Delwel R; Valk PJ; Löwenberg B; Ossenkoppele GJ
    Haematologica; 2008 Dec; 93(12):1894-8. PubMed ID: 19050070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of BECN1 in acute myeloid leukemia: association with distinct cytogenetic and molecular abnormalities.
    Zare-Abdollahi D; Safari S; Movafagh A; Ghadiani M; Tabarraee M; Riazi-Isfahani S; Gorji S; Keyvan L; Gachkar L
    Int J Lab Hematol; 2016 Apr; 38(2):125-32. PubMed ID: 26765290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the combination of serum l-kynurenine level and indoleamine 2,3-dioxygenase mRNA expression in acute myeloid leukemia.
    Hara T; Matsumoto T; Shibata Y; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Nannya Y; Shimizu M; Ito H; Saito K; Tsurumi H
    Leuk Lymphoma; 2016 Sep; 57(9):2208-11. PubMed ID: 26762931
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells.
    El Kholy NM; Sallam MM; Ahmed MB; Sallam RM; Asfour IA; Hammouda JA; Habib HZ; Abu-Zahra F
    Med Oncol; 2011 Mar; 28(1):270-8. PubMed ID: 20300979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations.
    Ryotokuji T; Yamaguchi H; Ueki T; Usuki K; Kurosawa S; Kobayashi Y; Kawata E; Tajika K; Gomi S; Kanda J; Kobayashi A; Omori I; Marumo A; Fujiwara Y; Yui S; Terada K; Fukunaga K; Hirakawa T; Arai K; Kitano T; Kosaka F; Tamai H; Nakayama K; Wakita S; Fukuda T; Inokuchi K
    Haematologica; 2016 Sep; 101(9):1074-81. PubMed ID: 27247325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of indoleamine 2,3-dioxygenase in acute myeloid leukemia.
    Sobash PT; Kolhe R; Karim NA; Guddati AK; Jillella A; Kota V
    Future Oncol; 2020 Dec; 16(36):3085-3094. PubMed ID: 32976029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.
    Folgiero V; Goffredo BM; Filippini P; Masetti R; Bonanno G; Caruso R; Bertaina V; Mastronuzzi A; Gaspari S; Zecca M; Torelli GF; Testi AM; Pession A; Locatelli F; Rutella S
    Oncotarget; 2014 Apr; 5(8):2052-64. PubMed ID: 24903009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCRP mRNA and FLT3-ITD are independent poor risk factors in adult patients with acute myeloid leukemia and intermediate or normal karyotype.
    Nasiłowska-Adamska B; Warzocha K; Solarska I; Borg K; Pieńkowska-Grela B; Czyż A
    Eur J Haematol; 2017 Sep; 99(3):255-261. PubMed ID: 28618074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia.
    Guo RJ; Atenafu EG; Schimmer AD; Minden MD; Chang H
    Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia.
    Mansour I; Zayed RA; Said F; Latif LA
    Hematology; 2016 Sep; 21(8):447-53. PubMed ID: 27077762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and Activity Regulation of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia Cells].
    Liao J; Li YP; Huang JM; Li G
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1633-1638. PubMed ID: 28024468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance].
    Wang YG; Liu XH; Liang Y; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):741-5. PubMed ID: 19176010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: its correlation with FLT3.
    Mehta SV; Shukla SN; Vora HH
    Neoplasma; 2013; 60(6):666-75. PubMed ID: 23906301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
    Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
    Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild chronic graft-versus-host disease may alleviate poor prognosis associated with FLT3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete remission: a retrospective study.
    Nasilowska-Adamska B; Czyz A; Markiewicz M; Rzepecki P; Piatkowska-Jakubas B; Paluszewska M; Dzierzak-Mietla M; Solarska I; Borg K; Prochorec-Sobieszek M; Szydlo R; Lewandowski K; Skotnicki A; Jedrzejczak WW; Kyrcz-Krzemien S; Komarnicki M; Warzocha K
    Eur J Haematol; 2016 Mar; 96(3):236-44. PubMed ID: 25912052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.